NEW YORK (Reuters Health) – Intensive insulin therapy in type 1 diabetics reduces their risks of neuropathy and retinopathy over the long-term, according to two papers published online…
David Heber, MD, Professor of Medicine, Director, UCLA Center for Human Nutrition, discusses nutrition in breast cancer, and the role of diabetes and obesity in post-menopausal breast cancer,…
NEW YORK (Reuters Health) – Researchers cut short a clinical trial of the endothelin blocker avosentan in patients with diabetic nephropathy because it was linked with fluid overload…
NEW YORK (Reuters Health) – As initial treatment of hypertension, a combination of benazepril plus amlodipine is more effective at preserving renal function compared to benazepril plus hydrochlorothiazide,…
NEW YORK (Reuters Health) – With intensive medical therapy, fewer than 5% of patients with asymptomatic carotid stenosis will gain additional benefit from revascularization, according to a report…
NEW YORK (Reuters Health) – Type 2 diabetics treated with rosiglitazone are at increased risk of heart failure events, researchers report in the January 29th online issue of…
NEW YORK (Reuters Health) – Limiting thyroid tests to high-risk women will miss most cases of thyroid dysfunction during pregnancy, randomized trial results show. Furthermore, when low-risk women…
NEW YORK (Reuters Health) – Potassium monitoring can help prevent drug-associated hyperkalemia events in patients with diabetes, according to a report in the January 20th online issue of…
NEW YORK (Reuters Health) – For patients with diabetes and complex multivessel coronary artery disease, the risk of repeat vascularization within one year is elevated 3-fold after percutaneous…
NEW YORK (Reuters Health) – In patients with schizophrenia, clozapine does not seem to increase the risk of cardiovascular death relative to risperidone, despite known differences in cardiometabolic…